Article
Genomic Alterations in DNA Mismatch Repair Genes Across Different Cancer Types.
JCO precision oncology - 1 Nov 2024
Holla Vijaykumar R, Kahle Michael P, Kim Sun-Hee, Ronaghy Arash, Yang Richard K, Patel Keyur P, Routbort Mark J, Overman Michael J, Dumbrava Ecaterina E, Mills Shaw Kenna R, Karp Daniel D, Meric-Bernstam Funda
Abstract excerpt
PURPOSE: PD-1 inhibition is effective in patients with mismatch repair deficient (dMMR) solid tumors in a tumor-agnostic fashion. However, dMMR testing by immunohistochemistry (IHC) is not routinely performed across tumor types. By contrast, next-generation sequencing (NGS) for somatic genomic alterations is frequently performed across tumor types. We hypothesized that NGS would identify patients with alterations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
